Clinical Trials Logo

Clinical Trial Summary

The digestive system is a pivotal component of human health, playing a crucial role in the absorption of nutrients, elimination of waste, and even influencing mental well-being. Poor digestive health can significantly impact one's quality of life and overall well-being. Issues such as bloating, constipation, or imbalanced gut microbiome can affect one's overall well-being. Moreover, the gut-brain connection underscores how digestive health can affect mental well-being. The gut can contribute to serotonin and energy production thus influencing one's mood, energy levels and cognitive functions, affecting one's emotional stability. Additionally, inadequate nutrient absorption from an imbalanced digestive system may lead to suboptimal health, weakening the body and causing fatigue. Overall, maintaining good digestive health is crucial not only for physical comfort but also for normal metabolism, immune function, cognitive abilities, sleep and skin health, ultimately enhancing the overall quality of life. Products designed by the sponsor contains a blend of ingredients recognized for their potential benefits in promoting digestive health (including prebiotics, probiotics, postbiotics, plant-based extracts and plant-based protein). Furthermore, it is well established in the literature that diet, exercise, hydration and mindfulness all impact our gut health and overall well-being. Therefore, this scientific study seeks to validate the efficacy of the combination of products and life-style changes by assessing its impact on gut health and related health aspects like weight, metabolic health, fitness level, energy/fatigue levels, satiety/hunger, food cravings, cognitive abilities and overall well-being.


Clinical Trial Description

This is a two-groups, virtual study where participants consume the green powder, probiotic and protein or meal replacement products and follow diet, hydration, physical activity and mindfulness activity regiment daily and provide feedback through the fitness tracker data, various questionnaires and measurement of basic biometrics over 30 days. The two-group design was chosen to obtain the data on the effects of the greens, probiotic products and protein vs a meal replacement food on a diverse group of participants. A virtual study ensures a broader reach and caters to the current trend of decentralized studies, which are more flexible and participant-centric. The choice of collecting daily fitness tracker data, spaced questionnaires and biometrics is to capture both immediate and cumulative effects of the products and the life-style regimen on the participants' health. A placebo has not been incorporated as it is not feasible to design a true placebo products that would taste and look indistinguishable from the intervention and placebo to the life-style regiment with a diet, physical activity, hydration, mindfulness activities are not feasible. The participants will be blinded to the sponsor name, brand name, and the exact products name. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06387251
Study type Interventional
Source Peryam & Kroll Research Corporation
Contact
Status Completed
Phase N/A
Start date January 29, 2024
Completion date February 29, 2024

See also
  Status Clinical Trial Phase
Completed NCT05595980 - The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults N/A
Completed NCT03749031 - Effects of Beverages Containing Orange or Apple Pomace on Digestive Health in Adults N/A
Recruiting NCT04917913 - Efficacy of a Digestive Enzyme Blend N/A
Completed NCT05004454 - Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults N/A
Completed NCT05303753 - Protein-Prebiotic Wellbeing Study N/A
Completed NCT05211440 - Microbial Enzyme Impact on Postprandial Nutrient Levels and Gastrointestinal Symptoms in Healthy Adults N/A
Completed NCT05957185 - Effects of Microbial Protease Supplementation on Postprandial Plasma Amino Acid Concentrations and Appetite N/A
Completed NCT05744700 - Safety and Tolerability Trial of Microbial Inulinase N/A